A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an Iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK): A structured summary of a study protocol for a randomised controlled trial

Abstract Objectives The objective of the study is to measure the efficacy of ionic-iodine polymer complex [1] for clinical and radiological improvement in coronavirus disease 2019 (COVID-19) patients. Trial design The trial will be closed label, randomized and placebo-controlled with a 1:1:1:1 alloc...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sohaib Ashraf, Shoaib Ashraf, Moneeb Ashraf, Muhammad Ahmad Imran, Larab Kalsoom, Uzma Nasim Siddiqui, Iqra Farooq, Muhammad Ghufran, Romaisa Arshad Khokhar, Muhammad Kiwan Akram, Iqra Shahid, Muhammad Sohaib Ur Rehman, Rutaba Akmal, Arbaz Tahir, Ayesha Zahid, Sidra Ashraf, Sundas Rafique, Nazish Matti, Muhammad Faisal Nadeem, Ayesha Humayun, Amber Malik, Qazi Abdul Saboor, Ali Ahmad, Muhammad Ashraf, Mateen Izhar
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-02-01
coleção:	Trials
Assuntos:	Iodine Pakistan COVID-19 Randomised controlled trial Protocol
Acesso em linha:	https://doi.org/10.1186/s13063-021-05081-3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!